The Massachusetts Male Aging Study found that ED prevalence rises steadily with age: some degree of ED was reported by about 52% of men aged 40 to 70, and complete ED tripled from about 5% at age 40 to 15% at age 70 [1]. But prevalence does not equal inevitability — and treatment for men over 50 is highly effective when causes are properly identified. The key difference from younger men: causes are rarely single, cardiovascular workup is essential, and medication interactions become a major factor.
What Actually Works for ED Over 50? Short Answer
The most effective approach for men over 50 is rarely a single medication — it's a coordinated combination addressing the multiple contributing factors that typically stack up by this age: a PDE5 inhibitor (usually tadalafil for its convenience and dual BPH benefit) as the immediate functional fix, a genuine cardiovascular risk assessment given ED's role as an early warning sign, testosterone testing since hormonal contribution becomes increasingly common, a review of every medication for ED-inducing side effects, and structured exercise, both cardiovascular and pelvic-floor-specific. Men who address only one piece — filling a PDE5 inhibitor prescription without touching the underlying vascular, hormonal, or medication factors — often see partial or inconsistent results, while men who work through the fuller picture see meaningfully better and more durable outcomes. This is the core reason ED treatment after 50 benefits from a more thorough initial workup than a quick prescription alone.
Why ED Is Different After 50
Under 40, ED is often predominantly psychological or due to a single identifiable cause. After 50, ED is typically multifactorial: endothelial dysfunction from years of atherosclerosis risk factors (the most common cause), declining testosterone, medications that impair erectile function, reduced pelvic floor muscle function, and a greater psychological burden. Each factor needs addressing.
The Role of Testosterone in ED After 50
Testosterone maintains libido, arousal, and the NO-cGMP pathway that PDE5 inhibitors depend on. Men with low testosterone often respond poorly to PDE5 inhibitors — not because the medication doesn't work, but because there's insufficient hormonal drive to initiate the arousal cascade. Testing testosterone before prescribing ED medication in men over 50 is clinically important.
Cardiovascular Health and ED: The Link
ED is increasingly recognized as an early warning sign of cardiovascular disease. The penile artery (1.5–2mm diameter) becomes obstructed before the coronary arteries (3.5mm) because endothelial dysfunction affects smaller vessels first. A man who develops ED without obvious cause at 50 has a significantly elevated risk of cardiovascular event within 3–5 years. Cardiovascular workup should accompany ED evaluation in men over 50.
Medications That Cause ED (And Alternatives)
- •Beta-blockers (carvedilol least, metoprolol more): discuss alternatives with cardiologist
- •Thiazide diuretics: associated with ED — calcium channel blockers or ACE inhibitors have less impact
- •SSRIs: significant sexual dysfunction — consider bupropion or mirtazapine if tolerated
- •5-alpha reductase inhibitors (finasteride, dutasteride): sexual side effects in 3–8% of users
- •Opioids: suppress testosterone — review pain management strategy
- •Spironolactone: anti-androgenic — alternatives may be available
What Works Best: Exercise, Meds, or Both?
For men over 50, the strongest evidence supports combining PDE5 inhibitors with pelvic floor exercise and cardiovascular exercise — not medication alone. A 2018 meta-analysis found men who combined PDE5 inhibitors with exercise had significantly better IIEF scores than those on medication alone. Exercise also reduces cardiovascular risk simultaneously.
Building a Realistic Treatment Sequence After 50
A practical sequence for a man over 50 newly evaluating ED typically starts with a thorough medical history and physical exam covering cardiovascular risk factors, current medications, and low-T symptoms, alongside baseline labs (testosterone, lipids, glucose, and blood pressure if not recently checked). A PDE5 inhibitor is often started concurrently rather than waiting for every other piece of the workup to complete, since it provides immediate functional benefit while the fuller picture is being assembled. As results come back, the plan adjusts: a medication swap if an ED-inducing drug is identified, TRT consideration if testosterone comes back genuinely low, and a referral to cardiology if the cardiovascular risk assessment reveals something needing dedicated attention. This staged, adjusting approach — rather than a single static prescription — reflects how ED care for this age group is best practiced, since the multifactorial nature of ED after 50 means the treatment plan often needs revision as each piece of information arrives.
ManCore's free daily log tracks erectile function, libido, and the lifestyle factors that influence them, so you can see what's actually helping over time.
What's Your Prostate Risk Score?
Take ManCore's free 6-question risk assessment. Get your personal risk score, see which supplements are most relevant to your profile, and get a clear action plan — in under 2 minutes.
Supplements for Erectile and Vascular Health
Snap Supplements Nitric Oxide Booster + Prostate Health
L-arginine pathway support for the healthy blood flow erectile function depends on.
Male Optimization Formula
General male-health formula pairing testosterone support with prostate care.
Affiliate disclosure: ManCore earns a small commission on purchases made through these links at no extra cost to you.
Frequently Asked Questions
ED treatment for older men
Effective treatment for men over 50 typically involves: cardiovascular workup + lifestyle modification, testosterone testing and correction if low, PDE5 inhibitor (tadalafil most convenient), pelvic floor exercises, and medication review for ED-causing drugs.
Erectile dysfunction at 55
At 55, the most common causes are vascular (endothelial dysfunction), low testosterone, medication side effects, and psychological factors. Treatment success rates remain high — 70–85% response to PDE5 inhibitors with lifestyle support.
Does testosterone help ED in older men?
Testosterone correction helps significantly when low T is confirmed (below 300 ng/dL). TRT alone does not resolve vascular ED — but it restores the hormonal environment that makes PDE5 inhibitors and natural arousal function properly.
Should men over 50 try lifestyle changes before starting ED medication?
They can be pursued in parallel rather than sequentially — starting a PDE5 inhibitor doesn't need to wait for lifestyle changes to take effect, since exercise and other lifestyle improvements typically take weeks to months to produce a measurable vascular benefit, while medication provides immediate functional support. Combining both from the start, rather than delaying medication until lifestyle changes are 'given a chance first,' tends to produce better outcomes and higher satisfaction, based on the exercise-plus-medication research showing the combination outperforms either alone.
Is it normal for ED treatment to require adjustment over time after 50?
Yes — since the underlying contributing factors (cardiovascular health, medications, testosterone levels) can shift over subsequent years, periodic reassessment rather than a one-time treatment plan makes sense for men in this age group. A PDE5 inhibitor dose that worked well initially might need adjustment as cardiovascular risk factors change, or a new medication started for an unrelated condition might introduce a new ED-contributing factor requiring the treatment plan to be revisited.
Does testosterone testing require a specific preparation the same way other blood work does?
Yes — testosterone specifically should be drawn in the morning (roughly 7-10am) on a fasting basis when possible, since testosterone follows a daily rhythm and can read meaningfully lower in the afternoon even in a man with genuinely normal levels. This is a frequently overlooked detail that can produce a falsely low result and an unnecessary diagnostic detour if the blood draw happens to be scheduled at a routine afternoon appointment rather than specifically timed for accurate testosterone measurement.
What if PDE5 inhibitors don't work well for a man over 50?
Non-response to an adequately dosed PDE5 inhibitor after several honest attempts (with adequate sexual stimulation, since these medications require arousal to work) is a signal to investigate further rather than simply concluding ED medication doesn't work. Common reasons include untreated low testosterone reducing the hormonal drive needed for the medication to work effectively, more severe vascular disease than a standard PDE5 inhibitor can overcome, or a psychological component requiring separate attention. Second-line options — intracavernosal injections, vacuum erection devices, or in more severe cases penile implants — remain effective for men over 50 who don't respond adequately to oral medication.
Does relationship or partner dynamics matter in ED treatment for older men?
Yes, and this is often underaddressed in a purely medical approach. Longer relationships can develop unspoken patterns around sexual frequency or expectations that compound the psychological burden of ED, and partner reassurance, open communication, and sometimes couples counseling meaningfully improve outcomes alongside medical treatment. Bringing a partner into the conversation with a doctor, when both parties are comfortable doing so, often produces a more complete and effective treatment plan than treating ED as a purely individual medical issue.
How often should a man over 50 on ED treatment have follow-up evaluation?
Annual reassessment is a reasonable baseline for a man stable on treatment, checking in on cardiovascular risk factors, testosterone if relevant, and overall satisfaction with the current approach, with more frequent visits warranted if any new symptoms, medication changes, or health events occur in between. Since ED after 50 is often an evolving picture tied to overall cardiovascular and hormonal health, treating it as a one-time fix rather than an ongoing part of general health monitoring tends to produce worse long-term outcomes than periodic reassessment.
Does diabetes change the treatment approach for ED over 50?
Yes, meaningfully — diabetic ED tends to involve both vascular and neurological damage, making it somewhat harder to treat than ED from vascular causes alone, and often requiring higher or more consistent PDE5 inhibitor dosing alongside tighter blood glucose control as part of the treatment plan. Men with diabetes and ED benefit particularly from the multifactorial evaluation approach discussed here, since diabetes frequently coexists with other ED-contributing factors (cardiovascular disease, low testosterone) that compound the diabetic-specific nerve and vessel damage.